{
    "id": 22523,
    "cites": 23,
    "cited_by": 1,
    "reference": [
        "American Cancer Society. (2014). HPV Vaccines. Retrieved from: http://www.cancer.org/cancer/cancercauses/othercarcinogens/infectiousagents/hpv/huma npapillomavirusandhpvvaccinesfaq/hpv-faq-vaccine-and-pap-testing Angrist, J.D., & Pischke, J.-S. (2009). Mostly Harmless Econometrics: An Empiricist\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s Companion. Princeton: Princeton University Press. 251-267.",
        "Brewer, N.T., & Fazekas, K. I. (2007). Predictors of HPV vaccine acceptability: a theoryinformed, systematic review. Preventive Medicine, 45.",
        "Budd, A. C., Brotherton, J. ML., Gertig, D. M., Chau, T., Drennan, K., Saville, M. (2014). Cervical Screening Rates for Women Vaccinated against Human Papillomavirus. The Medical Journal of Australia, 14(1): 279-282.",
        "Centers for Disease Control and Prevention. (2010). FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from the Advisory Committee on Immunization Practices (ACIP).",
        "Centers for Disease Control and Prevention. (2013). Gynecologic Cancer, Cervical Cancer Statistics. Retrieved from http://www.cdc.gov/cancer/cervical/statistics/ Centers for Disease Control and Prevention. (2014). Gynecologic Cancer, What Should I know about Screening. Retrieved from http://www.cdc.gov/cancer/cervical/basic_info/screening.htm Centers for Disease Control and Prevention. (2015). Human Papillomavirus (HPV), Information for Young Women-Fact Sheet. Retrieved from http://www.cdc.gov/std/hpv/stdfact-hpvvaccine -young-women.htm Dave, D. & Kaestner, R. (2009). Health Insurance and Ex Ante Moral Hazard: Evidence from Medicare. International Journal of Health Care Finance and Economics, 9(4): 367-390.",
        "Ehrlich, I., & Becker, G.S. (1972). Market Insurance, Self-Insurance, and Self-Protection. The Journal of Political Economy, 80(4): 623-648.",
        "Farre, L., Klein, R., & Vella, F. (2013). A Parametric Control Function Approach to Estimating the Returns to Schooling in the Absence of Exclusion Restrictions: An Application to the NLSY. Empirical Economics, 44(1): 111-133.",
        "Ferris, D. G., Waller, J., Dickinson, A., McCracken, C., & Goebel, A. (2012). Impact of Pap Test Compliance and Cervical Cancer Screening Intervals on Human Papillomavirus Vaccine Acceptance. Journal of Lower Genital Tract Disease, 16(1): 39-44.",
        "Franco, E. L., Cuzick, J., Hildesheim, A., & de, S. S. (2006). Chapter 20: Issues in Planning Cervical Cancer Screening in the Era of HPV Vaccination. Vaccine, 24: 171-7.",
        "Greene, W. H. (2007). Econometric analysis. Upper Saddle River, N.J: Prentice Hall, 6th edition.",
        "Hill, A. (2014). Medical Innovation and Moral Hazard: The Effect of HPV Vaccine on Risky Sexual Behavior. Working Paper.",
        "Howe, H. L., Wu, X., Ries, L. A. G., Cokkinides, V., Ahmed, F., Jemal, A., Miller, B., Edwards, B. K. (2006). Annual Report to the Nation on the Status of Cancer, 1975-2003, Featuring Cancer among U.S. Hispanic/Latino Populations. Cancer, 107(8): 1711-1742.",
        "Imbens, G.W., & Lemieux, T. (2008). Regression discontinuity designs: A guide to practice. Journal of Econometrics, 142(2): 615-635.",
        "Imbens, G., & Wooldridge, J. (2007a). What\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s New in Economterics? Regression Discontinuity Designs. Summer Institute 2007. Cambridge, MA: National Bureau of Economic Research.",
        "Imbens, G., & Wooldridge J. (2007b). What\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s New in Economterics? Control Function and Related Models. Summer Institute 2007. Cambridge, MA: National Bureau of Economic Research.",
        "Klick, J., & Stratmann, T. (2007). Diabetes Treatments and Moral Hazard. The Journal of Law & Economics, 50(3): 519.",
        "Margolis, J., Hockenberry, J. M., Grossman, M., & Chou, S-Y. (2014). Moral hazard and less invasive medical treatment for Coronary Artery Disease: The case of cigarette smoking. (NBER Working Paper No. 20373) Cambridge, MA: National Bureau of Economic Research.",
        "National Cancer Institute. (2014). Pap and HPV testing. Retrieved from http://www.cancer.gov/types/cervical/pap-hpv-testing-fact-sheet Peltzman, S. (2011). Offsetting Behavior, Medical Breakthroughs, and Breakdowns. Journal of Human Capital, 5(3): 302-341.",
        "Roblin, D. W., Chang, A., Roblin, D. W., Ritzwoller, D. P., Carroll, N. M., Daley, M. F., & Rees, D. I. (2014). The Influence of Deductible Health Plans on Receipt of the Human Papillomavirus Vaccine Series. Journal of Adolescent Health, 54(3): 275-281.",
        "Saslow, D., Castle, P. E., Cox, J. T., Davey, D. D., Einstein, M. H., Ferris, D. G., Goldie, S. J., & Garcia, F. (2007). American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors. CA: A Cancer Journal for Clinicians, 57(1): 7-28.",
        "Saslow, D., Runowicz, C. D., Solomon, D., Moscicki, A.-B., Smith, R. A., Eyre, H. J., & Cohen, C. (2002). American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer. Ca: a Cancer Journal for Clinicians, 52(6): 342-362.",
        "Skinner, S. R., Garland, S. M., Stanley, M. A., Pitts, M., & Quinn, M. A. (2008). Human papillomavirus vaccination for the prevention of cervical neoplasia: is it appropriate to vaccinate women older than 26? The Medical Journal of Australia, 188(4): 238-42.",
        "Van Der Klaauw, W. (2008). Regression-Discontinuity Analysis: A Survey of Recent Developments in Economics. LABOUR, 22: 219-245."
    ]
}